Howard Bregman
Recludix Pharma (United States)(US)
Publications by Year
Research Areas
Wnt/β-catenin signaling in development and cancer, Metal complexes synthesis and properties, Ion channel regulation and function, Ferrocene Chemistry and Applications, Cancer-related gene regulation
Most-Cited Works
- → Electrophilic properties of itaconate and derivatives regulate the IκBζ–ATF3 inflammatory axis(2018)705 cited
- → Ruthenium Half‐Sandwich Complexes Bound to Protein Kinase Pim‐1(2006)232 cited
- → An Organometallic Protein Kinase Inhibitor Pharmacologically Activates p53 and Induces Apoptosis in Human Melanoma Cells(2007)230 cited
- → Rapid Access to Unexplored Chemical Space by Ligand Scanning around a Ruthenium Center: Discovery of Potent and Selective Protein Kinase Inhibitors(2005)147 cited
- → Exploring Chemical Space with Organometallics: Ruthenium Complexes as Protein Kinase Inhibitors(2007)142 cited
- → An Organometallic Inhibitor for Glycogen Synthase Kinase 3(2004)125 cited
- → Crystal structures of human glycine receptor α3 bound to a novel class of analgesic potentiators(2016)123 cited
- → A Modular Synthesis of the Lamellarins: Total Synthesis of Lamellarin G Trimethyl Ether(2004)116 cited
- → Organometallic Compounds with Biological Activity: A Very Selective and Highly Potent Cellular Inhibitor for Glycogen Synthase Kinase 3(2006)115 cited
- → Effectiveness of COVID-19 mRNA Vaccination in Preventing COVID-19–Associated Hospitalization Among Adults with Previous SARS-CoV-2 Infection — United States, June 2021–February 2022(2022)104 cited